The effects of inhaled and oral corticosteroids on serum inflammatory biomarkers in COPD: an exploratory study
Background: Several studies suggest that inhaled and oral corticosteroids repress systemic inflammation in chronic obstructive pulmonary disease (COPD). However, the cytokines that may respond to these medications are unclear. Method: We used data from 41 patients with a history of stable moderate C...
Main Authors: | S.F. Paul Man, Xuekui Zhang, Rupert Vessey, Terry Walker, Kwan Lee, Dan Park, Don D. Sin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-04-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465809336697 |
Similar Items
-
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui SH, et al.
Published: (2018-11-01) -
Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
by: Liu SF, et al.
Published: (2016-07-01) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
by: Avdeev S, et al.
Published: (2019-06-01) -
COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
by: Ozcakir S, et al.
Published: (2020-10-01) -
Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
by: Koehorst-ter Huurne K, et al.
Published: (2016-07-01)